Wockhardt will exit its loss-making US generic business to focus on antibiotics and diabetes care. The company filed for ...

Wockhardt Ltd on July 11 said it has decided to exit US generic pharmaceutical segment to unlock capital for high-impact ...

Indian drug firm Wockhardt announces exit from its loss-incurring US generic business to concentrate on innovative ...

This multi-state settlement addresses makers of generic versions of opioids and is up to $720 million, officials said.

Trying to quickly turn a browser extension into a new revenue stream can backfire—common missteps can damage trust and tank ...

Amazon Prime Day 2025 deals on Thunderbolt docks and USB-C hubs are on now! We've rounded up all the best deals from Anker to ...

Mumbai: Wockhardt has announced a significant strategic realignment of its U.S. business, marking an exit from the generic ...

Discover why 90% of LinkedIn messages fail and learn how to create authentic connections that drive real results in 2025.

Wockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing ...

In today’s highly competitive business environment, it is no longer sufficient for firms (particularly small and medium-sized ...

The cover letter is more important than ever. In a world where AI can polish grammar and formatting, I use the cover letter ...

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...